Inventor · disambiguated record
Wesley Wehsin Han
Also filed as: HAN WESLEY W · HAN WESLEY WEHSIN
21 granted patents·25 pending applications·425 citations·filing 1982–2016
96Inventor score
Top patents by PatentIndex Score
46 records- 0194US6743439B1Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydrideALCON INC·Filed 2002·Granted Jun 1, 2004·82 cites·10 claims
- 0293US7977376B2Olopatadine formulations for topical nasal administrationNOVARTIS AG·Filed 2007·Granted Jul 12, 2011·28 cites·2 claims
- 0393US4559343ANonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agentsALCON LAB INC·Filed 1982·Granted Dec 17, 1985·54 cites·7 claims
- 0492US8399508B2Olopatadine formulations for topical nasal administrationSINGH ONKAR N·Filed 2011·Granted Mar 19, 2013·26 cites·2 claims
- 0588US6995186B2Olopatadine formulations for topical administrationALCON INC·Filed 2002·Granted Feb 7, 2006·33 cites·16 claims
- 0687US8268299B2Self preserved aqueous pharmaceutical compositionsKABRA BHAGWATI P·Filed 2007·Granted Sep 18, 2012·8 cites·28 claims
- 0785US8323630B2Self-preserved aqueous pharmaceutical compositionsKABRA BHAGWATI P·Filed 2011·Granted Dec 4, 2012·7 cites·11 claims
- 0881US4988728ASuprofen esters and amides as ophthalmic anti-inflammatory agentsALCON LAB INC·Filed 1990·Granted Jan 29, 1991·22 cites·8 claims
- 0977US8921337B2Carboxyvinyl polymer-containing nanoparticle suspensionsCHOWHAN MASOOD A·Filed 2010·Granted Dec 30, 2014·3 cites·15 claims
- 1077US7402609B2Olopatadine formulations for topical administrationALCON INC·Filed 2005·Granted Jul 22, 2008·3 cites·1 claims
- 1177US6284749B1Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soapALCON MFG LTD·Filed 1999·Granted Sep 4, 2001·42 cites·17 claims
- 1275US6146622AUse of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositionsALCON LAB INC·Filed 1999·Granted Nov 14, 2000·36 cites·18 claims
- 1374US6444710B1Use of certain fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositionsALCON MFG LTD·Filed 2001·Granted Sep 3, 2002·4 cites·17 claims
- 1470US9694021B2Pharmaceutical compositions with phosphonium antimicrobial agentsALCON RES LTD·Filed 2013·Granted Jul 4, 2017·1 cites·7 claims
- 1568US5013751A(+) Suprofen esters and amides as opthalmic anti-inflammatory agentsALCON LAB INC·Filed 1990·Granted May 7, 1991·10 cites·8 claims
- 1667US4737492ASparingly soluble salts of cefamandole, and ophthalmic compositions containing sameALCON LAB INC·Filed 1986·Granted Apr 12, 1988·7 cites·7 claims
- 1766US9446093B2Injectable aqueous ophthalmic composition and method of use thereforALCON RES LTD·Filed 2013·Granted Sep 20, 2016·0 cites·9 claims
- 1866US5620970ATopical ophthalmic carbonic anhydrase inhibitor formulationsALCON LAB INC·Filed 1995·Granted Apr 15, 1997·28 cites·12 claims
- 1963US6211238B1Preservative system for topically administrable pharmaceutical compositionsALCON LAB INC·Filed 1999·Granted Apr 3, 2001·25 cites·19 claims
- 2058US2008275122A1N-halogenated amino acid formulations with anti-inflammatory compoundsALCON RES LTD·Filed 2008·Application pending·0 cites
- 2158US2016361254A1Injectable aqueous ophthalmic composition and method of use thereforALCON RES LTD·Filed 2016·Application pending·0 cites
- 2257US2008275126A1Aliphatic acid-containing n-halogenated amino acid formulationsALCON RES LTD·Filed 2008·Application pending·0 cites
- 2357US2008093247A1Packaging materials for formulations containing 2-pyrrolidone derivativesALCON MFG LTD·Filed 2007·Application pending·0 cites
- 2457US2008275121A1N-halogenated amino acid formulations and methods for cleaning and disinfectionALCON RES LTD·Filed 2008·Application pending·0 cites
- 2556US2005065137A1Triamcinolone acetonide and anecortave acetate formulations for injectionALCON INC·Filed 2004·Application pending·0 cites
- 2655US4694022AFatty acid salts of betaxolol useful in the treatment of glaucomaALCON LAB INC·Filed 1986·Granted Sep 15, 1987·4 cites·6 claims
- 2755US2009197838A1Antimicrobial n-halogenated amino acid saltsALCON RES LTD·Filed 2008·Application pending·0 cites
- 2854US2013053440A1Self-Preserved Aqueous Pharmaceutical CompositionsALCON RES LTD·Filed 2012·Application pending·0 cites
- 2953US2010160342A1Compositions of Topical Ocular Solutions to Deliver Effective Concentrations of Active Agent to the Posterior Segment of the EyeALCON RES LTD·Filed 2009·Application pending·0 cites
- 3052US2014107121A1Olopatadine compositions and uses thereofALCON RES LTD·Filed 2013·Application pending·0 cites
- 3152US2006073172A1Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressureSCHNEIDER L W·Filed 2004·Application pending·0 cites
- 3250US2007149480A1PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYEALCON INC·Filed 2006·Application pending·0 cites
- 3349US2012053161A1Topical solution formulations containing a corticosteroid and a cyclodextrinCASTILLO ERNESTO J·Filed 2009·Application pending·0 cites
- 3449US2008275123A1N-halogenated amino acid formulationsALCON RES LTD·Filed 2008·Application pending·0 cites
- 3546US2011071091A1Injectable aqueous ophthalmic composition and method of use thereforCHOWHAN MASOOD A·Filed 2010·Application pending·0 cites
- 3645US2007148225A1PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYEALCON INC·Filed 2006·Application pending·0 cites
- 3745US2011269719A1Pharmaceutical compositions with phosphonium antimicrobial agentsCHOWHAN MASOOD A·Filed 2011·Application pending·0 cites
- 3845US2011124734A1N-halogenated amino acid formulations and methods for cleaning and disinfectionALCON RES LTD·Filed 2011·Application pending·0 cites
- 3944US2011082145A1Olopatadine compositions and uses thereofALCON RES LTD·Filed 2010·Application pending·0 cites
- 4044US2010210730A1N-halogenated amino acid formulations with anti-inflammatory compoundsALCON RES LTD·Filed 2010·Application pending·0 cites
- 4144US2007173538A1PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYEALCON INC·Filed 2006·Application pending·0 cites
- 4243US2011071116A1Antimicrobial n-halogenated amino acid saltsALCON RES LTD·Filed 2010·Application pending·0 cites
- 4342US2007149593A1PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYEALCON INC·Filed 2006·Application pending·0 cites
- 4436US2010204181A1N-halogenated amino acid formulations comprising phosphine or amine oxidesALCON RES LTD·Filed 2010·Application pending·0 cites
- 4534US2012022149A1Pharmaceutical composition with enhanced solubility characteristicsCHOWHAN MASOOD A·Filed 2011·Application pending·0 cites
- 4632US5008255AMethod for enhancing solubility of trimethoprim with sodium sulfacetamide, and synergistic pharmaceutical compositions derived therefromALCON LAB INC·Filed 1990·Granted Apr 16, 1991·2 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Wesley Wehsin Han files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →